PropertyValue
?:abstract
  • WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) is associated with increased risk of venous thromboembolism (VTE) Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization CASE SUMMARIES: We present 5 patients hospitalized for COVID-19 while on DOACs Four patients had atrial fibrillation and had a previous VTE Four patients developed acute VTE and one developed stroke-like symptoms Monitoring D-dimer assisted with the detection of VTE Three patients died, and two were discharged alive WHAT IS NEW AND CONCLUSION: Therapeutic failure with DOACs appears to be commonplace in COVID-19 Further research is needed to determine whether there is an underlying cause to this association
is ?:annotates of
?:creator
?:journal
  • J_Clin_Pharm_Ther
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants
?:type
?:who_covidence_id
  • #939769
?:year
  • 2020

Metadata

Anon_0  
expand all